The Life Raft Group is pleased to announce the release of the first issue of The GIST Cancer Journal, the official journal of the Life Raft Group and the first academic journal devoted solely to GIST. The journal is intended to serve as a comprehensive and authoritative resource of scientifically valid information for physicians and allied health care professionals regarding advances in the diagnosis and treatment of GIST. Editorial content focuses on the impact of translational research in oncology and gastroenterology relating specifically to GIST. As the official medical journal of the Life Raft Group, it also provides a forum for GIST patient advocacy. It will be published quarterly.
We are very pleased to have Dr. Jonathan Trent, Co-Director, Musculoskeletal Center, Director, Sarcoma Medical Research Program, and Professor of Medicine at the University of Miami in Miami, Florida as our Editor-in-Chief, as well as a medical advisory board consisting of some of the world’s most prominent physicians treating GIST – Dr. Peter Reichardt from the Helios Klinikum in Berlin, Germany; Dr. Matias Chacon from Instituto Medico Alexander Fleming in Buenos Aires, Argentina; Dr. Michael Heinrich from Oregon Health and Science University in Portland, Oregon; Dr. Andrew Rosenberg from the University of Miami in Miami, Florida, and Dr. Yoon-Koo Kang from Asan Medical Center in Seoul, South Korea.
Please see the journal’s website – http://gistsarcomajournal.com/ – to learn more about the journal and to read articles from the current issue. Print copies and article reprints can also be ordered via the website by contacting either email@example.com or firstname.lastname@example.org.